Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
3D illustration of tumor cells
New technology and research could help clinicians identify treatment strategies focused on specific areas in tumors, leading to better therapies for cancers and other diseases.

Location May Influence Tumor Cell’s Identity and Role in Cancer Biology

New approach could provide insights into cancer progression, treatment response, and precise therapies

National Institutes of Health
Published:Jun 27, 2023
|3 min read
Register for free to listen to this article
Listen with Speechify

Using 3D models of ovarian cancer tumors, scientists found differences in gene activity based on where a cell is in a tumor, demonstrating how a cell’s location and environment in a cancerous tumor can strongly influence which genes are active and the cell’s role in cancer biology. 

More specifically, the team co-led by researchers at the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, showed that gene activity in cells at or near a tumor’s surface differed from that of cells closer to the tumor center.

The approach pairs the use of technology to reveal the genetic activity of single cells within a tumor with fluorescent dyes that spread into tumors. The work could allow researchers to study how the same diseases can vary in people and progress differently. This research could help clinicians identify treatment strategies focused on specific areas in tumors, leading to better therapies for cancers and other diseases. The team reported its results recently in Cell Systems.

“It’s commonly accepted that a cell’s location and surrounding environment influence the cell’s identity,” said Craig Thomas, PhD, a translational scientist at NCATS. “Two cells can be genetically identical but have different cellular identities, meaning different genes are turned on because of their location and environment. Our goal was to establish a straightforward method to study this concept in multiple settings.”

New technology: Segmentation by exogenous perfusion (SEEP)

The new system, called segmentation by exogenous perfusion, or SEEP, takes advantage of a dye that diffuses into cells throughout a tumor at a definable rate. Measuring how much dye gets into individual tumor cells provides information on the cell’s location, and specifically, its access to the outside environment. 

Using computational methods, the researchers linked this information to cells’ gene activity, allowing the scientists to connect the cells’ identities with their location. “Understanding the relation of cells to each other and the effects of their positions in space has been a fundamental question in cancer, neurological disorders, and other areas,” said co-author Tuomas Knowles, PhD, at the University of Cambridge.

“It’s critical to understand that not every cell in a tumor will be exposed to a drug in the same way,” said Knowles. “A cancer drug might kill the cells on the surface of a tumor, but the cells in the middle are different and affected differently. That’s likely contributing to why some therapies fail.”

Differences in gene activity based on spatial arrangement 

The SEEP method revealed that tumor cells near the tumor surface were more likely to undergo cell division than cells closer to the tumor center. Cells on the surface of tumors also turn on genes to protect them from immune system responses. These gene responses are linked to how the tumor hides from the body’s immune defenses.

Researchers were surprised at the differences in gene activity between cells on or near the surface and those farther inside the ovarian cancer tumor models. The findings could help scientists better understand how tumors are structured. Such information could lead to improved treatments. One possible cancer treatment method could be to target cells likely to be affected in different areas of tumors.

“Certain tumor cell types are susceptible to certain therapies,” noted first author and Harvard University medical student, David Morse, PhD. “Knowing where cells are located and their levels of accessibility in the tumor could help us decide how to use drugs in combination. It could help tell us how long to give a drug and when to move on to other therapies.”

- This press release was originally published on the National Institutes of Health website